ArticleScientific reports2026
The study of nomogram model based on CT radiomics and clinical features for histological classification of parotid gland tumors.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Accurate preoperative identification of pathological types of parotid tumors is essential for the formulation of treatment decisions. The study aims to develop and validate a CT-based radiomics nomogram combining radiomics signature and clinical factors, and evaluate the effectiveness of different models in the classification of parotid gland tumors. A total of 427 patients with parotid gland tumors were randomly divided into a training set and a test set at a ratio of 7:3. Radiomic features were selected using the ANOVA and the LASSO regression. Three-step machine learning models were constructed using three common classifiers (LR, SVM and XGBoost) to classify the parotid gland tumors into four subtypes. The radiomics signature was constructed using the optimal radiomics model, and a radiomics score (Rad-score) was calculated. Clinical data and CT features were evaluated to build a clinical factor model. A radiomics nomogram incorporating the independent clinical factors and Rad-score was constructed. The evaluation of those models’ performance was executed by using receiver operator characteristics (ROC) curves (AUC) and calibration curves, and the clinical usefulness of these models was evaluated by decision curve analysis (DCA). In each step of the three-step procedure, twenty-seven, twelve, and thirteen valuable features were selected, respectively. And the radiomics model based on the LR, SVM, and LR classifiers obtained the highest AUC in differentiating BPGTs from MPGTs (AUC = 0.838), PA from WT & BCA (AUC = 0.847), and WT from BCA (AUC = 0.870), respectively. The nomogram, which combined the optimal radiomics model and independent clinical factors, achieved an improved classification performance (BPGTs vs. MPGTs, AUC = 0.849; PA vs. WT & BCA, AUC = 0.873; WT vs. BCA, AUC = 0.925). The calibration curve and the DCA demonstrated that the combined nomogram showed superior predictive performance than radiomics model and clinical factor model. The proposed nomogram of radiomics combined with clinical models has high clinical value for the preoperative classification of parotid gland tumors, which might hold promise in assisting clinicians in the exact preoperative diagnosis and formulation of personalized treatment strategy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.